Solanbridge Group Inc (SLNX)
0.00
USD |
OTCM |
Apr 30, 16:00
Solanbridge Group Max Drawdown (5Y): 99.94% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 99.94% |
March 31, 2024 | 99.94% |
February 29, 2024 | 99.94% |
January 31, 2024 | 99.94% |
December 31, 2023 | 99.94% |
November 30, 2023 | 99.94% |
October 31, 2023 | 99.94% |
September 30, 2023 | 99.94% |
August 31, 2023 | 99.94% |
July 31, 2023 | 99.94% |
June 30, 2023 | 99.94% |
May 31, 2023 | 99.94% |
April 30, 2023 | 99.94% |
March 31, 2023 | 99.94% |
February 28, 2023 | 99.94% |
January 31, 2023 | 99.94% |
December 31, 2022 | 99.94% |
November 30, 2022 | 99.94% |
October 31, 2022 | 99.94% |
September 30, 2022 | 99.94% |
August 31, 2022 | 99.92% |
July 31, 2022 | 99.92% |
June 30, 2022 | 99.92% |
May 31, 2022 | 99.92% |
April 30, 2022 | 99.92% |
Date | Value |
---|---|
March 31, 2022 | 99.92% |
February 28, 2022 | 99.92% |
January 31, 2022 | 99.92% |
December 31, 2021 | 99.92% |
November 30, 2021 | 99.92% |
October 31, 2021 | 99.92% |
September 30, 2021 | 99.92% |
August 31, 2021 | 99.92% |
July 31, 2021 | 99.92% |
June 30, 2021 | 99.92% |
May 31, 2021 | 99.92% |
April 30, 2021 | 99.92% |
March 31, 2021 | 99.92% |
February 28, 2021 | 99.99% |
January 31, 2021 | 99.99% |
December 31, 2020 | 99.99% |
November 30, 2020 | 99.99% |
October 31, 2020 | 99.99% |
September 30, 2020 | 99.99% |
August 31, 2020 | 99.99% |
July 31, 2020 | 99.99% |
June 30, 2020 | 99.99% |
May 31, 2020 | 99.99% |
April 30, 2020 | 99.99% |
March 31, 2020 | 99.99% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
99.92%
Minimum
Mar 2021
99.99%
Maximum
May 2019
99.95%
Average
99.94%
Median
Sep 2022
Max Drawdown (5Y) Benchmarks
NovaBay Pharmaceuticals Inc | 99.91% |
Palatin Technologies Inc | 96.46% |
iBio Inc | 99.97% |
Theriva Biologics Inc | 99.81% |
Oragenics Inc | 98.92% |